Gliknik Research

Gliknik is expert in immune modulation. We have several research platforms, each of which holds the promise of producing multiple innovative products:

The Immunomodulator Platform. Peptide cancer vaccine drugs that increase CD4, CD8, and antibody immune responses against targeted cancer epitopes.
The Stradomer^TM Platform. Recombinant drugs for a wide range of inflammatory and autoimmune diseases.
Stradomer^TM-coated Device Platform. A drug coating to prevent the body's normal reaction to implanted devices.
The Stradobody^TM Platform. Biologics similar to monoclonal antibodies with increased tumor cell killing.